The prevalence and persistence of human parvovirus B19 infection in thalassemic patients

Asian Pacific Journal of Allergy and Immunology

Volumn 25, Issue 2-3, 2007, Pages 169-174

  Siritantikorn, Sontana ^a   Kaewrawang, Sujittra ^a   Siritanaratkul, Noppadol ^a   Theamboonlers, Apiradee ^b   Poovorawan, Yong ^b   Kantakamalakul, Wannee ^a   Wasi, Chantapong ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; ERYTHEMA INFECTIOSUM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PERSISTENT INFECTION; PHYLOGENY; PREVALENCE; SEROPREVALENCE; THAILAND; THALASSEMIA; VIRUS STRAIN;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BASE SEQUENCE; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PHYLOGENY; SEROEPIDEMIOLOGIC STUDIES; THAILAND; THALASSEMIA;

EID: 36049009317     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gareus R, Gigler A, Hemauer A, et al. Characterization of cis-acting and NSI protein-responsive elements in the p6 promoter of parvovirus B19. J Virol 1998; 72: 609-16.
2. Saikawa T, Anderson S, Momoeda M, Kajigaya S, Young NS. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol 1993; 67: 3004-9.
3. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002; 15: 485-505.
4. Servant A, Laperche S, Lallemand F, et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002; 76: 9124-34.
5. Kovacs BW, Carlson DE, Shahbahrami B, Platt LD. Prenatal diagnosis of human parvovirus B19 in nonimmune hydrops fetalis by polymerase chain reaction. Am J Obstet Gynecol 1992; 167: 461-6.
6. Azzi A, Ciappi S, Zakvrzewska K, Morfini M, Mariani G, Mannucci PM. Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates. Am J Hematol 1992; 39: 228-30.
7. Anderson M1, Jones SE, Fisher-Hoch SP, et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1983; 1: 1378.
8. Neild G, Anderson M, Hawes S, Colvin BT. Parvovirus infection after renal transplant. Lancet 1986; 2: 1226-7.
9. White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA. Human parvovirus arthropathy. Lancet 1985; 1: 419-21.
10. Pattison JR, Jones SE, Hodgson J, et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaernia. Lancet 1981; 1: 664-5.
11. Lefrere JJ, Courouce AM, Girot R, Comu P. Human parvovirus and thalassaernia. J Infect 1986; 13: 45-9.
12. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988; 25: 151-3.
13. Sant'Anna AL, Garcia Rde C, Marzoche M, et al. Study of chronic hemolytic anaemia patients in Rio de Janeiro: prevalence of anti-human parvovirus B19 IgG antibodies and the development aplastic crises. Rev Inst Med Trop, Sao Paulo 2002; 44: 187-90.
14. Lundqvist A, Tolfvenstam T, Brytting M, Stolt CM, Hedman K, Broliden K. Prevalence of parvovirus B19 DNA in bone marrow of patients with haernatological disorders. Scand J Infect Dis 1999; 31: 119-22.
15. Lee YM, Tsai WH, You JY, et al. Parvovirus 1319 infection in Taiwanese patients with hernatological disorders. J Med Virol 2003; 71: 605-9.
16. Mortimer PP, Humphries RK, Moore JG, Purcell RH, Young NS: A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 1983; 302: 426-9.
17. Flunker G, Peters A, Wiersbitzky S, Modrow S. Seidel W. Persistent parvovirus B19 infections in immunocompromised children. Med Microbiol Immunol 1998; 186: 189-94.
18. Patou G, Pillay D, Myint S, Pattison J. Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19. J Clin Microbiol 1993; 31: 540-6.
19. Lim WL, Wong KF, Lau CS. Parvovirus B19 infection in Hong Kong. J Infect 1997; 35:247-9.
20. Poovorawan Y, Theamboonlers A, Suandork P. Hirsch P. Prevalence of antibodies to parvovirus B19 in Thailand. Southeast Asian J Trop Med Public Health 2000; 31: 422-4.
21. Bonvicini F. Gallinella G, Cricca M, et al. Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus. J Med Virol 2004; 74: 272-6.
22. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986; 58: 921-6.
23. Nguyen QT, Sifer C, Schneider V, et al. Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol 1999; 37: 2483-7.
24. Summers J, Jones SE, Anderson MJ. Characterization of the genome of the agent of erythrocyte aplasia permits its classification as a human parvovirus. J Gen Virol 1983; 64: 2527-32.
25. Hemauer A, von Poblotzki A, Gigler A, et al. Sequence variability among different parvovirus B19 isolates. J Gen Virol 1996; 77: 1781-5.